SEC 13F Intelligence

Cigna Investments Inc /New / LLY

Cigna Investments Inc /New’s Eli Lilly & Co Position

Does Cigna Investments Inc /New own Eli Lilly & Co (LLY)? Yes — 7.6K shares worth $7M (+1.08% of its 13F portfolio) as of Q1 2026, down from 7.7K shares the prior filed quarter.

Position Value
$7M
Q1 2026
Shares
7.6K
% of Portfolio
+1.08%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $3MQ2 ’19: $3MQ3 ’19: $3MQ4 ’19: $4MQ4 ’19Q1 ’20: $4MQ2 ’20: $6MQ3 ’20: $4MQ4 ’20: $5MQ4 ’20Q1 ’21: $5MQ2 ’21: $6MQ3 ’21: $6MQ4 ’21: $5MQ4 ’21Q1 ’22: $4MQ2 ’22: $3MQ3 ’22: $3MQ4 ’22: $4MQ4 ’22Q1 ’23: $3MQ2 ’23: $5MQ3 ’23: $5MQ4 ’23: $5MQ4 ’23Q1 ’24: $7MQ2 ’24: $8MQ3 ’24: $7MQ4 ’24: $6MQ4 ’24Q1 ’25: $7MQ2 ’25: $6MQ3 ’25: $6MQ4 ’25: $8MQ4 ’25Q1 ’26: $7Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20267.6K$7M+1.08%
Q4 20257.7K$8M+1.20%
Q3 20257.8K$6M+0.84%
Q2 20257.9K$6M+1.05%
Q1 20258.1K$7M+1.24%
Q4 20248.2K$6M+1.11%
Q3 20248.3K$7M+1.29%
Q2 20248.8K$8M+1.48%
Q1 20248.9K$7M+1.30%
Q4 20239.0K$5M+1.07%
Q3 20239.0K$5M+1.10%
Q2 202310.1K$5M+0.88%
Q1 202310.1K$3M+0.69%
Q4 202210.3K$4M+0.78%
Q3 202210.3K$3M+0.73%
Q2 202210.7K$3M+0.69%
Q1 202214.5K$4M+0.51%
Q4 202118.4K$5M+0.40%
Q3 202124.8K$6M+0.43%
Q2 202125.2K$6M+0.41%
Q1 202129.1K$5M+0.37%
Q4 202028.4K$5M+0.37%
Q3 202026.7K$4M+0.38%
Q2 202034.6K$6M+0.54%
Q1 202031.5K$4M+0.56%
Q4 201930.0K$4M+0.44%
Q3 201925.2K$3M+0.30%
Q2 201924.4K$3M+0.29%
Q1 201925.3K$3M+0.36%
Q4 201830.0K$3M+0.29%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cigna Investments Inc /New’s full portfolio or all institutional holders of LLY.